Haemonetics (HAE) Tops Q1 EPS by 5c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $119.79 +1.24%
Revenue Growth %: +5.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
PFBX, GOVB, VABK, More
Revenue Growth %: +5.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
PFBX, GOVB, VABK, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.14, $0.05 better than the analyst estimate of $1.09. Revenue for the quarter came in at $339 million versus the consensus estimate of $328.92 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- AptarGroup (ATR) Tops Q3 EPS by 5c
- Minerals Technologies (MTX) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
